By preventing macrophages from destroying phagocytized microorganisms, glucocorticoids lower natural resistance of the host against many pathogens. y-Interferon has an opposite effect and restores activity of dexamethasone-treated mononuclear phagocytes against some but not all microorganisms. In the present studies we show that dexamethasone impairs activity of human blood monocytes kept in culture for 36 h against Listeria monocytogenes, without impairing H202 or O2 secretion. Likewise dexamethasone does not interfere with activation of systems generating oxygen metabolites by lymphokines. Thus -interferon increases three-to fivefold the capacity of dexamethasone-treated monocytes to secrete O-or H202 upon stimulation by opsonized zymosan, live bacteria, or phorbol myristate acetate. Concurrently y-interferon restores listericidal activity of dexamethasone-treated monocytes. After gradual activation by exposure to '-interferon for progressive time periods, listericidal activity becomes tightly correlated (r = 0.922-0.994) with the amount of H202 or O-secreted by dexamethasone-treated monocytes. Activation of oxidative systems by the lymphokine is, however, not correlated with the restoration of activity against Aspergillus spores, lost during dexamethasone treatment, which does not depend on antimicrobial oxygen metabolites. Taken together, these observations lend to the hypothesis that glucocorticoids impair nonoxidative defense mechanisms of "resting" macrophages, while 'v-interferon restores macrophage function impaired by glucocorticoids by activating alternate killing systems, which are at least partly of oxidative nature.
Introduction
Glucocorticoids impair the antimicrobial activity of mononuclear phagocytes and affect by this mechanism natural immunity against bacteria and fungi in several models ofopportunistic infection (1) (2) (3) (4) . Glucocorticoids impair antimicrobial function by a direct hormonal effect on the phagocyte and prevent macrophages from killing and eliminating ingested microorganisms (2, 3, 5) . In contrast, lymphokines such as 'v-interferon enhance the antimicrobial activity of macrophages (5) (6) (7) and increase their capacity to secrete reactive oxygen intermediates (ROI)' (6) . We have previously reported that '-interferon restores the antimicrobial activity of human blood-derived macrophages exposed to glucocorticoids against Listeria monocytogenes and Salmonella typhimurium, two facultative intracellular bacteria susceptible to ROI, but not against microorganisms more resistant to ROI, such as Nocardia asteroides and Aspergillus spores (5) . We therefore speculated that glucocorticoids impair nonoxidative killing systems of mononuclear phagocytes operative in resting macrophages. Accordingly '-interferon by activating oxidative killing systems would overcome the functional impairment by glucocorticoids of resting cells and restore activity of macrophages against microorganisms susceptible to oxidants.
By investigating the effects of glucocorticoids and of '-interferon on secretion of ROT in relation to antimicrobial activity in human blood monocytes, we confirm in the present studies that glucocorticoids impair nonoxidative killing systems, operative in nonactivated, "resting" mononuclear phagocytes. After impairment ofthese antimicrobial functions by dexamethasone, activation of oxidative systems by 'v-interferon becomes tightly correlated to activity against Listeria monocytogenes but not to activity against Aspergillus spores, known to be independent from ROT. The correlation of ROT secretion with antimicrobial activity in human blood-derived macrophages simultaneously exposed to dexamethasone and 'v-interferon permits visualization of a distinct role in host defense for nonoxidative killing systems operative in "resting" mononuclear phagocytes, and ofother killing systems presumably at least in part of oxidative nature, operative in the activated state of the phagocyte.
Methods
Organisms. A lot ofthe Listeria monocytogenes strain EGD kept virulent by passage through mice was frozen in mid-log phase in trypticase soy broth at -70'C. For each experiment Listeria was grown as standing culture in trypticase soy broth at 370C overnight giving 1.2-1.9 X 109 CFU. Bacteria were washed three times in Gey's balanced salt solution, opsonized for 20 min in fresh human serum at 370C, and washed once more before dilution (1:12 to 1:15) in medium supplemented with 30% serum for infection of macrophages. This gave suspensions with a uniform cell count of 1-1.5 X 10 CFU ofbacteria per ml. Single-spore suspensions from a clinical isolate of Aspergillusfumigatus were obtained as described previously (5) .
Media, serum, and reagents. Trypticase soy broth and trypticase soy agar were from Difco Laboratories, Detroit, MI. Medium-199 cells from normal volunteers were separated by the Ficoll-Hypaque technique and monolayers were prepared on round 9-or 12-mm glass coverslips by a slight modification of the technique of Nagakawara et al. (8) as described previously (9) . In brief, 100 ul (for 12-mm coverslips) or 50 gl (for 9-mm coverslips) of a suspension of 1.5 X107 washed mononuclear cells in M-199 supplemented with 25% human serum was placed on coverslips in 35-mm tissue culture dishes (Falcon Plastics, Oxnard, CA). After incubation for 1 h at 370C for adhesion, coverslips were washed four times with prewarmed Gey's balanced salt solution and transferred into 16-mm diam plastic cluster plates (Falcon Plastics) and cultured in M-199 supplemented with 25% human serum and with additives or solvents (i.e., 0.0 1% of ethanol for dexamethasone, 0.1% phosphate-buffered saline for y-interferon) as indicated. Monolayers always consisted of 2 98% mononuclear phagocytes as determined by Giemsa stain and phagocytosis of Aspergillus spores (5) . Quantification of cell numbers from individual coverslips was done after exposure of monolayers to Zaponin (Coulter Electronics, Inc., Hialeah, FL) for stromatolysis and counting the freed nuclei in a model S counter (Coulter Electronics, Inc.). Cellular protein was measured by the method of Lowry (10), after solubilizing monolayers in 0.33 M NaOH, using bovine serum albumin as standard.
Quantification of production ofROI by macrophages. Secretion of H202 was studied by a modification of the method of Root et al. (11) which quantifies the loss of fluorescence of scopoletin resulting from oxidation by H202 in the presence of HRP. supplemented with 25% human serum. Subsequently (for baseline counts), and after incubation for 3 h, sets of four tubes were placed on ice, cells were lysed with ice-cold 0.1% deoxycholate (final concentration) in distilled water for exactly 15 min and serial dilutions of the lysate cultured on trypticase soy agar for determination of CFU (3). Under these conditions deoxycholate had no effect on the viability of Listeria. Results ofthe assay are given as the change in CFU in percentage ofthe baseline values after incubation ofbacteria and macrophages for 3 h after phagocytosis from quadruplicate tubes.
Statistical analysis. Values are given as mean±SD or ±SEM as indicated. The relation between killing of bacteria and the respiratory burst was evaluated by simple linear regression (16) . Mean values were compared by t test (16) .
Results
Effects of dexamethasone, y-interferon, and dexamethasone plus y-interferon on secretion ofROI by human blood monocytes kept in culturefor 36 h. Exposure of blood-derived macrophages to high pharmacologic concentrations ofdexamethasone for 36 h, a regimen shown previously to abolish antimicrobial activity (5), had no effect on the amount of H202 secreted by "resting" macrophages upon stimulation by PMA or opsonized zymosan as determined in an endpoint assay (Fig. 1) . Dexamethasone did also not interfere with the activation of systems responsible for increased secretion of H202 by (Fig. 1) . Comparable results were obtained by measuring H202 secretion by chemiluminescence amplified by peroxidase and luminol (Fig. 2) , which permitted us to evaluate individual monolayers with as little as 4 X I04 cells. The observation that activation ofmacrophages occurs in the presence of dexamethasone was further confirmed by measuring secretion of 0°by lucigenin-amplified chemiluminescence (Fig. 3 ). This system, in which chemiluminescence is not lessened by catalase, permitted us to investigate, in addition, secretion of ROI induced by phagocytosis oflive Listeria, an intracellular pathogen with high catalase activity. We were particularly interested in chemiluminescence directly induced by Listeria, because we have reported that Listeria is killed by resting blood-derived macrophages but not by resting mononuclear phagocytes exposed to dexamethasone. Furthermore, we had found that the listericidal activity of macrophages activated by y-interferon was not diminished by dexamethasone (5). Besides we had found a similar impairment of antimicrobial activity by dexamethasone in blood-derived macrophages from children with chronic granulomatous disease, which are unable to secrete important amounts of ROI, and therefore had speculated (5) (Fig. 4) . We next turned to the problem of analyzing quantitatively the correlation between ROI secreted by macrophages with listericidal activity. In preliminary experiments we found that exposure of macrophages to graded concentrations of y-interferon for 36 h did not reproducibly result in accordingly graded increments in the amount ofsecreted ROI, presumably because of the steep dose-response curve with a barely detectable activity at 1-2 U/ml and maximal activity at concentrations between 5 and 10 U/ml (data not shown). Therefore we elected to expose macrophages for progressively longer time spans to a fully activating concentration of y-interferon in order to obtain monolayers secreting progressively increasing amounts of ROI (Figs. 1 and 5) . Moreover, exposure of dexamethasone-treated macrophages to y-interferon for progressively longer time spans resulted in an increasingly higher listericidal activity in a test system based on quantitative cultures measuring the change in CFU of Listeria monocytogenes associated to macrophage monolayers after vigorous washing over time (Fig. 6) antibiotics are added to the culture medium, measured activity of macrophages directed against ingested Listeria. As shown by the tight relation between the change in CFU with the fate of intracellular Listeria followed visually over time by counting the number of parasitized macrophages, the results of the assay depending on quantitative cultures were not blurred by growth of extracellular bacteria (Fig. 7) . Additionally, the comparison of the two assays also excludes the possibility that the main antilisterial activity would go unnoticed in the CFU-type assay during initial incubation for 15 ROT, i.e., secretion of H202 and O°. These experiments confirmed that resting mononuclear phagocytes which secreted only a modest amount of H202 had a high antilisterial activity which could barely be improved by activating systems responsible for secretion of ROT by 7-interferon (Fig. 8) . Resting blood-derived macrophages exposed to dexamethasone lost their antilisterial activity independently from an impairment of the modest secretion of H202 of resting phagocytes, which was identical to that of control cells (Fig. 8) . Dexamethasone again did not disturb activation of systems responsible for secretion of H202 (Fig. 8) . However, in contrast to control monocytes which were already very active against Listeria in their "resting" state, activation of H202 -secreting systems in dexamethasone-exposed cells by 7-interferon resulted reproducibly in a tight correlation between antilisterial activity and secretion of H202 (Fig. 8) . Comparable results were obtained in three additional independent experiments relating listericidal activity to secretion of°2 measured by lucigenin-amplified chemiluminescence (Fig. 9) .
Taken together these results suggested that resting human blood-derived macrophages efficiently killed Listeria monocytogenes by nonoxidative killing systems. Activation of alternate killing systems such as those responsible for secretion of ROI could therefore' not substantially increase listericidal-act tivity' of normal monocytes not exposed to dexamethasone. In contrast, after elimination of nonoxidative antilisterial aptivity by dexamethasone, gradual activation of oxidative killing systems was paralleled by an according increment of the antilisterial activity, proportional to the amount of H202 or secreted in answer to y-interferon. This concept was further substantiated by demonstrating that the antimicrobial actiyity of macrophages against Aspergillus spores, which is independent from oxidative killing systems (5, 9), could not be restored by 7-interferon in. dexamethasone-treated cells despite of activated oxidative systems -and reestablished antilisterial activity (Table I) .
Discussion
These studies on the interrelation of the effects of glucocorticoids and of the macrophage-activating lymphokine y-interferon on macrophage function show that glucocorticoids impair antimicrobial activity ofhuman blood monocytes without affecting secretion of antimicrobial oxygen met~abolites by nonactivated, resting phagocytes and without preventing an enhancement of oxidative killing systems during activation by 7y-interferon.
Glucocorticoids lower antimicrobial activity of macrophages, an immunosuppressive mechanism which appears to be critical for the effect ofglucocorticoids on host resistance in several models of opportunistic infections such as listeriosis (3, 4) , mycobacteriosis (1), and aspergillosis (2). We haye previously reported that the deleterious effect of therapeutic glucocorticoid concentrations on macrophage function results from a direct, receptor-mediated steroid effect on the capacity of mononuclear phagocytes to kill ingested bacteria and fungal spores (2, 5) . Based on observations that glucocorticoids impair antimicrobial activity of resting macrophages from patients with chronic granulomatous disease, which are unable to produce significant amounts of antimicrobial ROI, and from normal donors alike, we have proposed that glucocorticoids impair nonoxidative killing systems of "resting" macrophages (5) . The present studies show that dexamethasone at pharma- (Figs. 8 and 9 ). The importance of alternate, probably oxidative, killing systems is only brought out in this model after elimination ofthe dexamethasone-sensitive antilisterial activity. After a glucocorticoid-induced loss of antilisterial activity, gradual activation of systems generating ROI is paralleled by an accordingly increased activity against Listeria in dexamethasone-exposed cells (Figs. 8 and 9 ). That it is not merely a restoration ofthe function of the dexamethasone-sensitive, nonoxidative killing systems by y-interferon can be shown by demonstrating that the defect in the antimicrobial activity against microorganisms which are more resistant against ROI such as Aspergillus spores (5, Table I ) or Nocardia asteroides (5) persists in dexamethasone-exposed cells, despite of activated systems generating ROI. It appears therefore important to consider the susceptibility of a particular microorganism to the various killing systems of the phagocytic armature in studies of the functional modulation of antimicrobial activity of macrophages. For the same reasons it appears logical that glucocorticoids do not necessarily reduce activity of resting macrophages against all pathogens.
In conclusion, our studies indicate that dexamethasone impairs nonoxidative killing systems of resting macrophage which are operative against a broad spectrum of bacteria and fungi (e.g., Listeria, Salmonella, Nocardia, and Aspergillus). 
